Study of EPI-003 in Select Nucleos(t)Ide Analogue-Treated, Chronic Hepatitis B Patients

NCT06661148 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis B
HBV (Hepatitis B Virus)

Interventions

DRUG: EPI-003

Sponsor

Epigenic Therapeutics, Inc